Skip to main content

DexCom to Present at the Canaccord Adams Diabetes and Obesity Conference

DexCom, Inc. (NASDAQ:DXCM) today announced that Terrance Gregg, President and Chief Executive Officer, will present an update on DexCom at the Canaccord Adams Diabetes and Obesity Conference in New York on Tuesday, May 12, 2009 at 2:20 p.m. (EDT). The presentation, which will occur live at The InterContinental Barclay Hotel in New York City, will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com under the investor webcast section and will be archived for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

Cautionary Statement Regarding Forward Looking Statements

DexCom is a medical device company with a limited operating history. Successful commercialization of the company’s products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company’s development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company’s annual report on Form 10-K for the period ending December 31, 2008, as filed with the Securities and Exchange Commission on March 5, 2009.

Contacts:

DexCom, Inc.
Steven R. Pacelli, Chief Administrative Officer, 858-200-0200

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.